Skip to Main Content

Paper Details

Phase I Study of High-Dose L-methylfolate in Combination with Temozolomide and Bevacizumab in Recurrent IDH wild-type High-Grade Glioma.
Cancer Res Commun
0
2022
Author NameAffiliation
Lucas A SalasGeisel School of Medicine at Dartmouth
Thomas G StewartVanderbilt University Medical Center
Sudan N LoganathanVanderbilt University Medical Center
Mitchel S Berger
Mitchel S Berger
Devin Absher
Devin Absher
Brock C ChristensenGeisel School of Medicine at Dartmouth
Brock C ChristensenGeisel School of Medicine at Dartmouth
  • 1 - 9

Datasets

Release 1.2